Beside these well-known molecules there is a vast unknown world of tiny RNAs (RiboNucleic Acids) that might play a crucial role in a number of cellular processes. Those elements are named noncoding RNAs (ncRNA) and they play their...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BIO2012-40244
DESARROLLO DE RECURSOS COMPUTACIONALES PARA LA CARACTERIZACI...
105K€
Cerrado
YRNAcleave
Sequence and structural requirements for Y RNA cleavage
195K€
Cerrado
PID2020-119715GB-I00
DESCUBRIMIENTO DE LAS PALABRAS EPIGENETICAS DE LA REGULACION...
105K€
Cerrado
BFU2017-82773-P
EXPLORANDO LA FUNCION DEL TRANSCRIPTOMA LARGO NO CODIFICANTE...
305K€
Cerrado
BIOINFOBANK INSTITUTE
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
30K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Beside these well-known molecules there is a vast unknown world of tiny RNAs (RiboNucleic Acids) that might play a crucial role in a number of cellular processes. Those elements are named noncoding RNAs (ncRNA) and they play their function without transcription to the protein product. Here is proposed development of integrated bioinformatics platform that is specifically addressed for detecting, verifying, and classifying of noncoding RNAs. This complex approach to "Computational RNomics" will provide the pipeline which will be capable of detecting RNA motifs with low sequence conservation. It will also integrate RNA motif prediction which should significantly improve the quality of the RNA homolog search. The first commercial application is the integrated system for detection of new regulatory elements located in the non coding genome parts. Up to now numerous human disorders have been found to be related to some of the noncoding RNA’s The second application of the project is so called RNA nanotechnology. It is designing of artificial nanoparticles, which are assembled mainly from ribonucleic acid which possess both the right size and ability to gain entry into cells and halt viral growth or cancer's progress or deliver drugs. The project will benefit from latest achievements in High Performance Computing and General-Purpose computing on Graphics Processing Units and Graph theory.